Use daily, morning and evening, for best results
When Your Peptide Guide summarizes CJC-1295 and Ipamorelin, we show where the evidence stops so your next step is based on source material, not repetition
Choosing the wrong one doesnt mean danger it means wasted time and money solving the wrong problem
1 Nebulized treatments may especially be beneficial for elderly patients and patients who have difficulties with achieving adequate inspiratory flow, coordinating single-breath actuation, or holding breath for the required time after dose delivery
Trial evidence: Tesamorelin 2mg SC daily sustained GH/IGF-1 elevation, 15-18% visceral fat reduction over 6 months (Falutz, NEJM 2007, PMID 17699044) Ipamorelin 200-300 mcg peak GH 5-10x baseline within 30 minutes, no cortisol/prolactin bump (Raun, EJE 1998, PMID 9539826) GHRH + GHRP synergy 2-3x greater amplitude than either alone (Bowers, JCEM 1991, PMID 2004615) Community protocols extend this evidence base with cycling patterns that weren't studied in the original trials the 5-on/2-off rhythm and 8-week cycles are empirical community consensus, not clinically validated
In this light, we focus on one of the complications of chronically uncontrolled hyperglycemia: end-stage kidney disease, which necessitates kidney replacement therapy
